Jiang Zhong Pharmaceutical Co.,Ltd (SHA:600750)
China
· Delayed Price · Currency is CNY 23.11
-0.01 (-0.04%)
May 16, 2025, 2:45 PM CST
SHA:600750 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 804.09 | 788.19 | 718.67 | 598.24 | 505.69 | 473.74 | Upgrade
|
| Depreciation & Amortization | 134.75 | 134.75 | 126 | 122 | 115.44 | 112.77 | Upgrade
|
| Other Amortization | 3 | 3 | 0.86 | 0.45 | 0.3 | 0.28 | Upgrade
|
| Loss (Gain) From Sale of Assets | -1.84 | -1.84 | -1.22 | 0.13 | -0.9 | 0.21 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1.05 | 1.05 | 2.04 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 9.6 | 9.6 | 40.05 | -61.47 | -51.25 | 15.98 | Upgrade
|
| Provision & Write-off of Bad Debts | 8.67 | 8.67 | -0.34 | 1.34 | -0.31 | 1.65 | Upgrade
|
| Other Operating Activities | 74.8 | -7.96 | 15.87 | 34.65 | 16.69 | 16.35 | Upgrade
|
| Change in Accounts Receivable | -326.87 | -326.87 | 257.89 | 9.75 | 159.5 | 240.6 | Upgrade
|
| Change in Inventory | 10.82 | 10.82 | -50 | -3.3 | -23.63 | -6.54 | Upgrade
|
| Change in Accounts Payable | 175.97 | 175.97 | -65.85 | 309.96 | 200.5 | -92.82 | Upgrade
|
| Change in Other Net Operating Assets | 3.63 | 3.63 | 8.94 | 10.66 | 1.19 | - | Upgrade
|
| Operating Cash Flow | 884.91 | 786.25 | 1,039 | 1,022 | 917.04 | 752.5 | Upgrade
|
| Operating Cash Flow Growth | -15.16% | -24.36% | 1.73% | 11.42% | 21.87% | 17.36% | Upgrade
|
| Capital Expenditures | -282.12 | -290.77 | -211.15 | -345.73 | -188.49 | -182.53 | Upgrade
|
| Sale of Property, Plant & Equipment | 13.9 | 13.89 | 0.25 | 0.05 | 1.24 | 0.66 | Upgrade
|
| Cash Acquisitions | - | - | - | - | 197.89 | - | Upgrade
|
| Investment in Securities | 164.93 | 234.93 | 39.68 | 370.87 | -1,308 | -506.43 | Upgrade
|
| Other Investing Activities | 117.44 | 122.91 | 56.65 | 43.48 | 60.98 | 29.51 | Upgrade
|
| Investing Cash Flow | 14.15 | 80.97 | -114.58 | 68.67 | -1,237 | -658.8 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 30 | - | - | Upgrade
|
| Total Debt Issued | - | - | - | 30 | - | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -30 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -1.55 | -1.95 | -2.17 | -0.8 | - | Upgrade
|
| Total Debt Repaid | -1.55 | -1.55 | -1.95 | -32.17 | -0.8 | - | Upgrade
|
| Net Debt Issued (Repaid) | -1.55 | -1.55 | -1.95 | -2.17 | -0.8 | - | Upgrade
|
| Issuance of Common Stock | - | - | - | 8.89 | 37.96 | - | Upgrade
|
| Repurchase of Common Stock | -1.31 | -1.31 | -1.12 | -2.32 | -73.27 | - | Upgrade
|
| Common Dividends Paid | -768.46 | -768.46 | -816.52 | -733.1 | -313.37 | -157.5 | Upgrade
|
| Other Financing Activities | -85.63 | -86.12 | -13.48 | - | - | -5.88 | Upgrade
|
| Financing Cash Flow | -856.95 | -857.44 | -833.07 | -728.7 | -349.48 | -163.38 | Upgrade
|
| Net Cash Flow | 42.12 | 9.78 | 91.82 | 361.72 | -669.02 | -69.68 | Upgrade
|
| Free Cash Flow | 602.79 | 495.49 | 828.31 | 676.02 | 728.55 | 569.97 | Upgrade
|
| Free Cash Flow Growth | -27.78% | -40.18% | 22.53% | -7.21% | 27.82% | 0.91% | Upgrade
|
| Free Cash Flow Margin | 13.87% | 11.17% | 18.19% | 17.40% | 25.35% | 23.34% | Upgrade
|
| Free Cash Flow Per Share | 0.95 | 0.79 | 1.15 | 1.07 | 1.15 | 0.90 | Upgrade
|
| Cash Income Tax Paid | 535.45 | 532.47 | 485.59 | 421.79 | 392.17 | 391.59 | Upgrade
|
| Levered Free Cash Flow | 266.36 | 253.67 | 541.68 | 517.63 | 862.86 | 348.06 | Upgrade
|
| Unlevered Free Cash Flow | 267.43 | 254.74 | 546.04 | 520.37 | 865.02 | 349.27 | Upgrade
|
| Change in Net Working Capital | 169.52 | 156.75 | -91.8 | -341.3 | -617.02 | -88.45 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.